Chocolate milk, Will Smith, and the concussion study nobody could read

Michael Walter | | Health Imaging | Neuroimaging

When the movie “Concussion” starring Will Smith hit theaters, a chocolate milk company wanted to use the opportunity to promote its drink’s ability to help young athletes recover from concussions, according to a new report by the Associated Press.

The AP points out that this is the continuation of an ongoing saga involving the company, Fifth Quarter Milk.

Back in December 2015, a press release came out promoting the milk’s effectiveness at “improving the cognitive and motor functions of high school football players, even after they suffered concussions.” But the actual study was never released to the public.

Click below for the full scoop from the AP, which was shared by ABC News: 

Chocolate Milk Maker Wanted Study Touted With "Concussion"

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

More than 1/3 of old strokes are incidentally detected on head CT
AI-based ARIA detection software could bring 'renewed hope' for people undergoing Alzheimer's treatment
Dual energy CT parameters help determine the type of clot behind strokes
Socioeconomic disadvantage during childhood linked to altered brain structure later in life, MRIs show
The Mediterranean diet may slow brain aging, MRI study shows
Researchers receive grant worth millions to develop portable PET scanner

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.